Loading...
Ideally, nonsteroidal antiinflammatory drugs (NSAIDs) would be stopped when gastroduodenal side effects occur, but many patients depend on these drugs. This randomized trial compared omeprazole (20 mg or 40 mg daily) and ranitidine (150 mg twice a day) in 541 patients who had endoscopically diagnosed gastroduodenal ulcers or erosions while taking NSAIDs, and who needed ongoing NSAID therapy (usually for arthritis). Most patients had dyspeptic symptoms.
At eight weeks, the rate of success (defined as ulcer healing, fewer than five erosions, and no more than mild dyspepsia) was significantly higher with omeprazole than ranitidine (80 percent vs. 63 percent). The 20 mg dose of omeprazole was as good as the 40 mg dose. Omeprazole was superior to…